Mardi Dier is CFO and CBO of Acelyrin Inc.
Person profile
Roles
Acelyrin
CFO and CBO
Ultragenyx Pharmaceutical
CFO & Executive Vice President
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ACELYRIN, Inc.
11 May 23
4
ACELYRIN, Inc.
4 May 23
3
ACELYRIN, Inc.
4 May 23
4
Ultragenyx Pharmaceutical Inc.
17 Oct 22
4
Ultragenyx Pharmaceutical Inc.
14 Oct 22
4
Ultragenyx Pharmaceutical Inc.
19 Sep 22
4
Prelude Therapeutics Inc
22 Jun 22
4
Oric Pharmaceuticals, Inc.
17 Jun 22
4
Ultragenyx Pharmaceutical Inc.
3 Mar 22
4
Ultragenyx Pharmaceutical Inc.
14 Oct 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 May 23 | SLRN Acelyrin | Common Stock | Buy | Acquire P | Yes | No | 18 | 875 | 15.75 k | 875 |
9 May 23 | SLRN Acelyrin | Common Stock | Buy | Acquire P | Yes | No | 18 | 875 | 15.75 k | 875 |
9 May 23 | SLRN Acelyrin | Common Stock | Buy | Acquire P | No | No | 18 | 5,556 | 100.01 k | 5,556 |
9 May 23 | SLRN Acelyrin | Employee Stock Option Common Stock | Other | Acquire J | No | No | 18 | 85,226 | 1.53 mm | 85,226 |
9 May 23 | SLRN Acelyrin | Employee Stock Option Class A Common Stock | Other | Dispose J | No | No | 18 | 85,226 | 1.53 mm | 0 |
9 May 23 | SLRN Acelyrin | Employee Stock Option Common Stock | Other | Acquire J | No | No | 5.8766 | 673,621 | 3.96 mm | 673,621 |
9 May 23 | SLRN Acelyrin | Employee Stock Option Class A Common Stock | Other | Dispose J | No | No | 5.8766 | 673,621 | 3.96 mm | 0 |
4 May 23 | SLRN Acelyrin | Employee Stock Option Class A Common Stock | Grant | Acquire A | No | No | 18 | 85,226 | 1.53 mm | 85,226 |
14 Oct 22 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | Yes | 40.16 | 1,629 | 65.42 k | 66,695 |
12 Oct 22 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 38.22 | 3,484 | 133.16 k | 68,324 |